Dudediligence.

NanoViricides, Inc

NNVCAMEX · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$3.1MSep ’24−$2.0MDec ’24−$2.2MMar ’25−$2.1MJun ’25−$1.8MSep ’25−$2.2MDec ’25−$2.0MMar ’26−$2.2MJun ’26
Fiscal years, by the month each ended
LineJun 2022Jun 2023Jun 2024Jun 2025Jun 2026
Revenuenone on file$0.00$0.00$0.00$0.00
Operating income−$8.1M−$8.9M−$8.5M−$9.6M−$8.3M
Net income−$8.1M−$8.6M−$8.3M−$9.5M−$8.2M
Operating cash flow−$5.9M−$5.7M−$6.3M−$8.5M−$7.7M
Free cash flow−$6.2M−$5.8M−$6.5M−$8.5M−$7.8M
Cash$14.1M$8.1M$4.8M$1.6M$2.8M
Shares outstanding11.6M11.7M13.1M16.6M23.0M